Tempus AI, Inc. (NASDAQ:TEM) Shares Sold by Blair William & Co. IL

Blair William & Co. IL cut its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 48.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,839 shares of the company's stock after selling 6,475 shares during the period. Blair William & Co. IL's holdings in Tempus AI were worth $231,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of TEM. ARK Investment Management LLC increased its holdings in Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock valued at $186,343,000 after buying an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. raised its holdings in Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after purchasing an additional 1,651,996 shares during the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in shares of Tempus AI during the 4th quarter worth $13,504,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Remove Ads

Insider Buying and Selling at Tempus AI

In other news, major shareholder Bradley A. Keywell sold 265,000 shares of Tempus AI stock in a transaction that occurred on Friday, January 17th. The stock was sold at an average price of $35.10, for a total value of $9,301,500.00. Following the completion of the transaction, the insider now owns 15,218,365 shares in the company, valued at approximately $534,164,611.50. This trade represents a 1.71 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jennifer A. Doudna sold 1,320 shares of the firm's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $90.00, for a total value of $118,800.00. Following the transaction, the director now owns 36,011 shares in the company, valued at $3,240,990. This trade represents a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,581,969 shares of company stock worth $316,538,582 in the last ninety days.

Tempus AI Stock Down 8.7 %

Tempus AI stock traded down $3.70 during midday trading on Tuesday, hitting $39.00. 10,483,391 shares of the stock were exchanged, compared to its average volume of 5,392,049. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The company has a 50 day moving average price of $58.09 and a two-hundred day moving average price of $51.40. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $91.45.

Wall Street Analysts Forecast Growth

TEM has been the subject of several recent research reports. Needham & Company LLC raised their target price on shares of Tempus AI from $56.00 to $70.00 and gave the company a "buy" rating in a report on Tuesday, February 25th. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price target for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Wolfe Research downgraded Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, Morgan Stanley lifted their target price on Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $61.18.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.